Impact of pre-hydration duration on high-dose methotrexate induced nephrotoxicity in childhood acute lymphoblastic leukaemia in resource constraint centers: a randomized crossover study
- PMID: 36951972
- DOI: 10.1007/s00280-023-04525-8
Impact of pre-hydration duration on high-dose methotrexate induced nephrotoxicity in childhood acute lymphoblastic leukaemia in resource constraint centers: a randomized crossover study
Abstract
Purpose: Hydration before starting high-dose methotrexate (HD-MTX) ensures good renal perfusion and alkaline urinary pH. The duration of pre-hydration is not uniform across protocols. We compared 6-h versus 12-h of pre-hydration for HD-MTX therapy in childhood acute lymphoblastic leukaemia (ALL) at our centre where serial MTX level monitoring is not feasible.
Methods: This randomised cross-over study consecutively enrolled children < 12 years with ALL receiving HD-MTX. Children with pre-existing renal disease or those exposed to nephrotoxic drugs were excluded. Two groups receiving 6-h versus 12-h pre-hydration on alternate basis in same patient (each exposed to four cycles of 2-5 g/m2 of HD-MTX) were compared for HD-MTX induced nephrotoxicity (primary outcome) and other HD-MTX toxicities (HMT) as per common terminology criteria for adverse events (CTCAE-4.0). HD-MTX was administered over 24 h as per BFM-protocol-2009. Solitary MTX levels at 36-h (MTX36) were outsourced and leucovorin (LV) was started at 36 h at 15 mg/m2/dose for 6-8 doses 6-hourly depending on MTX36. Hydration fluid was dextrose normal saline with sodium-bicarbonate and administered till last LV dose.
Results: Total 136 HD-MTX cycles in 34 patients (age range 5-144 months) were evaluated. Nephrotoxicity [2/68 (2.9%) in 6-h versus 1/68 (1.5%) in 12-h] and HMT incidence was comparable in two pre-hydration groups. Median MTX36 levels were not affected by duration of hydration irrespective of administered dose of HD-MTX. Median serum creatinine at baseline, post-pre-hydration and at 36-h post start of HD-MTX were comparable.
Conclusion: Reduction of pre-hydration duration does not affect HD-MTX induced nephrotoxicity and MTX36 levels in children < 12 years.
Keywords: Acute lymphoblastic leukaemia; Children; High-dose methotrexate; Low-middle income countries; Methotrexate toxicities; Pre-hydration.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Solitary serum methotrexate level 36 hours post high-dose methotrexate: A safe, efficacious, and cost-effective strategy to monitor methotrexate toxicities in childhood leukemia in resource-limited centers.Pediatr Blood Cancer. 2020 Jul;67(7):e28387. doi: 10.1002/pbc.28387. Epub 2020 May 13. Pediatr Blood Cancer. 2020. PMID: 32400952
-
Hypoalbuminemia and not undernutrition predicts high-dose methotrexate-induced nephrotoxicity in children with acute lymphoblastic leukemia in resource-constrained centers.Pediatr Blood Cancer. 2022 Sep;69(9):e29738. doi: 10.1002/pbc.29738. Epub 2022 Apr 21. Pediatr Blood Cancer. 2022. PMID: 35451162
-
Improving the safety of high-dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin.Pediatr Blood Cancer. 2018 Dec;65(12):e27241. doi: 10.1002/pbc.27241. Epub 2018 May 16. Pediatr Blood Cancer. 2018. PMID: 29768710 Clinical Trial.
-
How to rescue high-dose methotrexate induced nephrotoxicity and literature review about hemodiafiltration?Pak J Pharm Sci. 2020 May;33(3):1163-1167. Pak J Pharm Sci. 2020. PMID: 33191243 Review.
-
The effect of leucovorin rescue therapy on methotrexate-induced oral mucositis in the treatment of paediatric ALL: A systematic review.Crit Rev Oncol Hematol. 2019 Oct;142:1-8. doi: 10.1016/j.critrevonc.2019.07.003. Epub 2019 Jul 9. Crit Rev Oncol Hematol. 2019. PMID: 31323533
Cited by
-
Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy.Cancer Chemother Pharmacol. 2024 Jul;94(1):89-101. doi: 10.1007/s00280-024-04664-6. Epub 2024 Mar 13. Cancer Chemother Pharmacol. 2024. PMID: 38478074 Free PMC article. Clinical Trial.
-
A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment.J Cancer Res Clin Oncol. 2024 Oct 2;150(10):441. doi: 10.1007/s00432-024-05945-6. J Cancer Res Clin Oncol. 2024. PMID: 39356310 Free PMC article. Review.
References
-
- Christensen ML, Rivera GK, Crom WR, Hancock ML, Evans WE (1988) Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia. J Clin Oncol 6(5):797–801. https://doi.org/10.1200/JCO.1988.6.5.797 . (PMID: 3163362) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical